Retina
Diabetes, central serous retinopathy, retinopathy of prematurity, occupational health
Friday, June 6
1045-1215
Room: 200 E
Objectives
At the end of this session, participants will be able to:
To come
Guest
Marco Zarbin, MD
|
Moderator
J. Whelan
|
Schedule and description
| 1045 | Introduction |
| 1050 | Controversies in the management of wet AMD
Marco Zarbin |
| 1120 | Discussion |
| 1130 | Prevalence, severity and predictors of diabetic retinopathy among First Nations people in northern BC
Lisa Weger, Peggy Yen, Andrew Jin, David Maberley |
| 1125 | Discussion |
| 1127 | Canadian assessment of real-world efficacy and safety of dexamethasone intravitreal implant in patients with DME
Tom Sheidow, Wai-Ching Lam, Darryl Baptiste, Hany Phillips |
| 1132 | Discussion |
| 1134 | Bevacizumab vs. laser for the treatment of ROP. Comparison of visual function, structural outcomes and frequency of follow-up
Nasrin N. Tehrani, Maram Isaac, Kamiar Mireskandari |
| 1139 | Discussion |
| 1141 | Oral mineralocorticoid antagonists for the treatment of central serous chorioretinopathy
David R. Almeida, Eric Chin, James C. Folk, Stephen R. Russell |
| 1146 | Discussion |
| 1148 | Intravitreal anti-VEGF in the treatment of chronic central serous chorioretinopathy. A systematic review of the literature
Haley Augustine, Monique Munro, Feisal Adatia |
| 1153 | Discussion |
| 1155 | Effects of hazardous ocular laser exposure in commercial airline pilots. A retrospective chart review
Mathew Palakkamanil, Michael Fielden |
| 1200 | Review and open discussion |
COS-7 Clinical update: retina
Friday, June 6
1330-1500
Room: 200 CD
Objectives
At the end of this session, participants will be able to:
- Review cataract-related complications and management
- Update in retinal imaging
- Discuss how antibiotics can influence endophthalmitis after intravitreal injections
Guests
Brandon Ayres, MD
Peter Barry, MD
Terrence O’Brien, MD
Srinivas Sadda, MD
Marco A. Zarbin, MD
|
Moderators
Arif Samad
James Whelan
|
Schedule and description
| 1330 | Introduction |
| 1335 | Update on the management of retinal venous occlusive diseaseSrinivas Sadda |
| 1350 | Discussion |
| 1355 | Management of endophthalmitis after ocular trauma
Marco Zarbin |
| 1410 | Discussion |
| 1415 | Dislocated IOL repair
Brandon Ayres |
| 1430 | Discussion |
| 1435 | Endophthalmitis after intraocular injections - Where are we?
Peter Barry
|
| 1445 | Infection after intravitreal injection:
avoidance and management
Terry O'Brien
|
| 1455 | Discussion |
Retina AMD
Saturday, June 7
1045-1215
Room: 303
Objectives
At the end of this session, participants will be able to:
- Update advancements in imaging for AMD
- Recognize imaging patterns of AMD that necessitate early intervention
- Review treatment schedules for exudative AMD and their outcomes
Guest
Srinivas Sadda, MD
|
Moderators
Gilles Desroches
Arif Samad
|
Schedule and description
| 1045 | Introduction |
| 1050 | Insights into the pathogenesis of AMD revealed by OCT
Srinivas Sadda |
| 1120 | Discussion |
| 1125 | Prospective evaluation of tele-ophthalmology in initial screening for suspected exudative AMD
Bo Li, Anne Marie Powell, Philip Hooper, Tom Sheidow |
| 1130 | Discussion |
| 1132 | An analysis of SD-OCT features that influence conversion to neovascular AMD in high-risk patients
Gary Yau, Lisa Jagan, Sanjay Sharma |
| 1137 | Discussion |
| 1139 | Retrospective review of Lucentis "treat and extend" patterns and outcomes in AMD
Tom Sheidow, Yufeng Chen, Alex Mao, Anne Marie Powell |
| 1144 | Discussion |
| 1146 | OCT-based predictions of geographic atrophy development in AMD
Nawaaz A. Nathoo, Chris Or, Mei Young, Lica Chui, Nader Fallah, Andrew Kirker, David A. Albiani, Andrew B. Merkur, Farzin Forooghian |
| 1151 | Discussion |
| 1153 | Inhibition of the innate immune response with TMi-018 reduces the development of RPE loss in a model of dry AMD
Shelley R. Boyd, Xu Zhao, David S. Baek, Natalie Pankova, Hai Wang |
| 1158 | Open discussion |
Retinal imaging, tumours, and macular causes of vision loss
Saturday, June 7
1330-1500
Room: 303
Objectives
At the end of this session, participants will be able to:
To come
Guests
Srinvas Sadda, MD
|
Moderator
Wai-Ching Lam
|
Schedule and description
| 1330 | Introduction |
| 1333 | What's next in OCT
Srinivas Sadda |
| 1348 | Discussion |
| 1352 | Predictive value of peripheral non-perfusion in retinal venous occlusive disease
Srinivas Sadda |
| 1407 | Discussion |
| 1411 | Structural abnormalities of the macula as causes of decreased vision post-successful primary retinal detachment repair
Alice Y. Zhang, Sulaiman Al-Humaid, Christina Ryu, Michael A. Kapusta, John Galic, John C. Chen |
| 1416 | Discussion |
| 1418 | Delivery recommendations for healthy pregnant women with risk factors for rhegmatogenous retinal detachment. Current practice among Canadian ophthalmologists and obstetricians
Hannah Chiu, Donna Steele, Chryssa McAlister, Wai-Ching Lam |
| 1423 | Discussion |
| 1425 | Predictive factors for the spontaneous resolution of vitreomacular traction
David R. Almeida, Eric Chin, James C. Folk, Karim Rahim, Stephen R. Russell |
| 1430 | Discussion |
| 1432 | Clinical guidelines for idiopathic epiretinal membranes: a systematic review of the literature and survey of current practice
Myra C. Butler, David Maberley |
| 1437 | Discussion |
| 1439 | Test characteristics of point-of-care ultrasonography for the diagnosis of acute posterior ocular pathology
David M. Stitt, Michael Woo, Nathan Hecht, Bernard Hurley, Paul Pageau, Jame Worrall, Mark Reardon, Mark Taylor, Venkatash Thiruganasambandamoorthy |
| 1451 | Discussion |
| 1446 | Treatment of tumour margin recurrence of choroidal melanoma post-125-iodine brachytherapy with transpupillary thermotherapy
Salah Alrashidi, E. Rand Simpson, Hatem Krema |
| 1451 | Discussion |
| 1453 | Zostavax-induced acute retinal necrosis
Jeremy A. Murphy, Andrew Boswall, Christopher Seamone |
| 1458 | Discussion |
|
